Leveraging Immunopeptidomics To Study and Combat Infectious Disease
T cells must recognize pathogen-derived peptides bound to major histocompatibility complexes (MHCs) in order to initiate a cell-mediated immune response against an infection, or to support the development of high-affinity antibody responses. Identifying antigens presented on MHCs by infected cells...
Guardado en:
Autores principales: | Owen K. Leddy, Forest M. White, Bryan D. Bryson |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
American Society for Microbiology
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/933d0ab64c25497f97fe5f6157b51f9f |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Biocontainment in Gain-of-Function Infectious Disease Research
por: W. Ian Lipkin
Publicado: (2012) -
Preserve a Voucher Specimen! The Critical Need for Integrating Natural History Collections in Infectious Disease Studies
por: Cody W. Thompson, et al.
Publicado: (2021) -
The Principles of Antibody Therapy for Infectious Diseases with Relevance for COVID-19
por: Arturo Casadevall, et al.
Publicado: (2021) -
Emerging Infectious Diseases in 2012: 20 Years after the Institute of Medicine Report
por: David M. Morens, et al.
Publicado: (2012) -
Host-Microbe Metagenomics: a Lens To Refocus Our Perspective on Infectious and Inflammatory Diseases
por: Katrina L. Kalantar, et al.
Publicado: (2021)